These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 38050337

  • 1. Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model-informed drug development case study.
    Clegg LE, Chu L, Nagard M, Boulton DW, Penland RC.
    CPT Pharmacometrics Syst Pharmacol; 2024 Feb; 13(2):296-307. PubMed ID: 38050337
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.
    Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S.
    BMC Nephrol; 2022 Feb 08; 23(1):59. PubMed ID: 35135481
    [Abstract] [Full Text] [Related]

  • 4. Potassium-lowering effects of sodium zirconium cyclosilicate in the early post-transplant period.
    Shockey W, Wiegel JJ, Parajuli S, Garg N, Swanson KJ, Mandelbrot DA.
    Clin Transplant; 2024 Jan 08; 38(1):e15156. PubMed ID: 37812572
    [Abstract] [Full Text] [Related]

  • 5. Population Pharmacodynamic Dose-Response Analysis of Serum Potassium Following Dosing with Sodium Zirconium Cyclosilicate.
    Penland RC, Åstrand M, Boulton DW, Någård M.
    Clin Pharmacokinet; 2024 Apr 08; 63(4):551-560. PubMed ID: 38504082
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C, Nassar T, Qunibi W.
    Expert Opin Pharmacother; 2021 Jan 08; 22(1):19-28. PubMed ID: 32892634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E, Ruegger M, Dunne I, Sutaria N, Towers WF.
    Am J Health Syst Pharm; 2023 Sep 07; 80(18):1238-1246. PubMed ID: 37335862
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S.
    J Am Soc Nephrol; 2019 Sep 07; 30(9):1723-1733. PubMed ID: 31201218
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An evaluation of sodium zirconium cyclosilicate: a new treatment option for hyperkalaemia in China.
    Lu Y, Liu BC, Liu H.
    Expert Opin Pharmacother; 2023 Feb 07; 24(3):301-308. PubMed ID: 36617700
    [Abstract] [Full Text] [Related]

  • 15. Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia.
    Yoo N, Song YB, Dubinsky I, Altshuler J.
    Ann Pharmacother; 2023 Sep 07; 57(9):1044-1052. PubMed ID: 36637028
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese Patients.
    Ni Z, Lu R, Xu X, Bian X, Zhou Z, Yang J, Luo Q, Chen M, Chen C, Sun X, Yu L, He Q, Jiang H, Yuan W, Li Y, Zhou R, Wang J, Zhang X, Zuo L, Meng X, Chang Z, Zhao J, Wessman P, Xiang P, DIALIZE China Study Group.
    Clin Ther; 2023 Jul 07; 45(7):633-642. PubMed ID: 37385905
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of sodium zirconium cyclosilicate on acid-base balance in chronic kidney disease.
    Mori D, Namiki Y, Sugimachi A, Kado M, Tamai S, Nomi H, Haga R, Nagatoya K, Yamauchi A.
    Clin Nephrol; 2022 May 07; 97(5):255-260. PubMed ID: 34958299
    [Abstract] [Full Text] [Related]

  • 20. Fecal ammonium in mice with CKD: gastrointestinal sequestration by sodium zirconium cyclosilicate.
    Marmol F, Badaruddin M, Baig A, Ye M, Wysocki J, Tahaei E, Welling P, Bamberg K, Batlle D.
    Am J Physiol Renal Physiol; 2023 May 01; 324(5):F464-F471. PubMed ID: 37022945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.